The Public Financing of Pharmaceuticals
Editor
- Jaume Puig-Junoy
Abstract
Individual chapters are listed in the "Chapters" tab
Suggested Citation
Download full text from publisher
Book Chapters
The following chapters of this book are listed in IDEAS- J. Puig-Junoy, 2005. "Introduction: Public Pharmaceutical Expenditure," Chapters, in: Jaume Puig-Junoy (ed.), The Public Financing of Pharmaceuticals, chapter 1, Edward Elgar Publishing.
- P. Ibern Regàs, 2005. "Incentives for innovation in the pharmaceutical market," Chapters, in: Jaume Puig-Junoy (ed.), The Public Financing of Pharmaceuticals, chapter 2, Edward Elgar Publishing.
- J. Puig-Junoy, 2005. "Price regulation systems in the pharmaceutical market," Chapters, in: Jaume Puig-Junoy (ed.), The Public Financing of Pharmaceuticals, chapter 3, Edward Elgar Publishing.
- J.R. Borrell Arqué & A. Costas Comesa-a & R. Nonell Torres, 2005. "Regulation and competition in pharmaceutical markets," Chapters, in: Jaume Puig-Junoy (ed.), The Public Financing of Pharmaceuticals, chapter 4, Edward Elgar Publishing.
- J. Rovira Forns & J. Darbà Coll, 2005. "Mechanisms to encourage price competition in the pharmaceutical market and their effects on efficiency and welfare," Chapters, in: Jaume Puig-Junoy (ed.), The Public Financing of Pharmaceuticals, chapter 5, Edward Elgar Publishing.
- G. López-Casasnovas & J. Puig-Junoy, 2005. "Reference pricing as a pharmaceutical reimbursement mechanism," Chapters, in: Jaume Puig-Junoy (ed.), The Public Financing of Pharmaceuticals, chapter 6, Edward Elgar Publishing.
- B. González López-Valcárcel, 2005. "Insurance in public financing of pharmaceuticals," Chapters, in: Jaume Puig-Junoy (ed.), The Public Financing of Pharmaceuticals, chapter 7, Edward Elgar Publishing.
- J.L. Pinto Prades & X. Badía Llach, 2005. "Economic evaluation and pharmaceutical policy," Chapters, in: Jaume Puig-Junoy (ed.), The Public Financing of Pharmaceuticals, chapter 8, Edward Elgar Publishing.
- L. Cabiedes & V. Ortún, 2005. "Prescriber incentives," Chapters, in: Jaume Puig-Junoy (ed.), The Public Financing of Pharmaceuticals, chapter 9, Edward Elgar Publishing.
- G. López-Casasnovas, 2005. "Economic considerations regarding pharmaceutical expenditure in Spain and its financing," Chapters, in: Jaume Puig-Junoy (ed.), The Public Financing of Pharmaceuticals, chapter 10, Edward Elgar Publishing.
- F. Lobo & M. Caba-as Sáenz & R. González Pérez, 2005. "Review of economic studies of the pharmaceutical industry published over the last 20 years by Spanish economists," Chapters, in: Jaume Puig-Junoy (ed.), The Public Financing of Pharmaceuticals, chapter 11, Edward Elgar Publishing.
More about this item
Keywords
Economics and Finance;JEL classification:
- H0 - Public Economics - - General
Statistics
Access and download statisticsCorrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:elg:eebook:3627. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Darrel McCalla (email available below). General contact details of provider: http://www.e-elgar.com .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.